Insiders Flerie Invest AB

Equities

FLERIE

SE0008966295

Delayed Nasdaq Stockholm Other stock markets 06:40:10 27/06/2024 pm IST			5-day change	1st Jan Change
0.476 ^SEK	-0.83%		-4.61%	+87.50%

14/06	Alligator Bioscience Names New CFO	MT
13/06	InDex Pharmaceuticals Holding AB will Change its Name to Flerie AB	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alligator Bioscience Names New CFO	14/06	MT
InDex Pharmaceuticals Holding AB Approves the Election of Karl Tobieson as Board Member	07/05	CI
Index Pharmaceuticals Holding AB Announces Board Resignations	05/04	CI
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease	26/03	MT
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO	26/03	CI
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024	26/03	CI
InDex Pharmaceuticals Holding AB Announces Composition of the Nomination Committee	30/23/30	CI
InDex Pharmaceuticals Holding AB Announces Appointment of Nomination Committee for the 2023 Annual General Meeting	26/22/26	CI
InDex Pharmaceuticals Holding AB Appoints Jenny Sundqvist as New CEO, Effective January 1, 2023	10/22/10	CI
InDex Pharmaceuticals Holding AB Announces Board Appointments	01/22/01	CI
InDex Pharmaceuticals Names New Chief Development Officer, Chief Medical Officer	02/22/02	MT
InDex Pharmaceuticals Strengthens the Organization with Eva Arlander as Chief Development Officer and Announces Changes in the Composition of the Management Team	02/22/02	CI
InDex Pharmaceuticals CEO Resigns	11/22/11	MT
InDex Pharmaceuticals Holding AB Announces CEO Changes	11/22/11	CI
InDex Pharmaceuticals COO To Step Down To Pursue WntResearch CEO Post	14/22/14	MT
InDex Pharmaceuticals Holding AB Announces Resignation of Pernilla Sandwall as Chief Operating Officer	14/22/14	CI
Index Pharmaceuticals Holding AB Announces Composition of Nomination Committee	10/21/10	CI
InDex Pharmaceuticals Holding AB Announces Appointment of Anders Bröijersén Is Joining Index as Senior Medical Director Clinical Operations and Johan Levin as Project Manager Clinical Operations	23/21/23	CI
InDex Pharmaceuticals Holding AB Announces Resignations	03/21/03	CI
InDex Pharmaceuticals Holding AB : announces changes in the Nomination Committee for the 2021 Annual General Meeting	16/21/16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Flerie Invest AB

Equities

FLERIE

SE0008966295

Insiders

Filters